BMRN
Price
$56.65
Change
+$1.38 (+2.50%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
10.6B
60 days until earnings call
ITOS
Price
$10.19
Change
+$0.01 (+0.10%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
390.01M
62 days until earnings call
Interact to see
Advertisement

BMRN vs ITOS

Header iconBMRN vs ITOS Comparison
Open Charts BMRN vs ITOSBanner chart's image
BioMarin Pharmaceutical
Price$56.65
Change+$1.38 (+2.50%)
Volume$45.97K
Capitalization10.6B
iTeos Therapeutics
Price$10.19
Change+$0.01 (+0.10%)
Volume$9.42K
Capitalization390.01M
BMRN vs ITOS Comparison Chart
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. ITOS commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Buy and ITOS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (BMRN: $58.09 vs. ITOS: $10.06)
Brand notoriety: BMRN and ITOS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 109% vs. ITOS: 1025%
Market capitalization -- BMRN: $10.6B vs. ITOS: $390.01M
BMRN [@Biotechnology] is valued at $10.6B. ITOS’s [@Biotechnology] market capitalization is $390.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileITOS’s FA Score has 1 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • ITOS’s FA Score: 1 green, 4 red.
According to our system of comparison, ITOS is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 2 TA indicator(s) are bullish while ITOS’s TA Score has 6 bullish TA indicator(s).

  • BMRN’s TA Score: 2 bullish, 3 bearish.
  • ITOS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ITOS is a better buy in the short-term than BMRN.

Price Growth

BMRN (@Biotechnology) experienced а -0.67% price change this week, while ITOS (@Biotechnology) price change was +22.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

BMRN is expected to report earnings on Aug 05, 2025.

ITOS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.6B) has a higher market cap than ITOS($390M). ITOS YTD gains are higher at: 30.990 vs. BMRN (-11.623). BMRN has higher annual earnings (EBITDA): 651M vs. ITOS (-153.09M). BMRN has more cash in the bank: 1.14B vs. ITOS (495M). ITOS has less debt than BMRN: ITOS (5.1M) vs BMRN (603M). BMRN has higher revenues than ITOS: BMRN (2.85B) vs ITOS (35M).
BMRNITOSBMRN / ITOS
Capitalization10.6B390M2,718%
EBITDA651M-153.09M-425%
Gain YTD-11.62330.990-38%
P/E Ratio20.47N/A-
Revenue2.85B35M8,154%
Total Cash1.14B495M230%
Total Debt603M5.1M11,833%
FUNDAMENTALS RATINGS
BMRN: Fundamental Ratings
BMRN
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
77
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMRNITOS
RSI
ODDS (%)
N/A
Bearish Trend 10 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 10 days ago
64%
Bearish Trend 10 days ago
79%
Momentum
ODDS (%)
Bearish Trend 10 days ago
79%
Bullish Trend 10 days ago
80%
MACD
ODDS (%)
Bearish Trend 10 days ago
68%
Bullish Trend 10 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 10 days ago
64%
Bullish Trend 10 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 10 days ago
62%
Bullish Trend 10 days ago
74%
Advances
ODDS (%)
Bullish Trend 18 days ago
60%
Bullish Trend 25 days ago
72%
Declines
ODDS (%)
Bearish Trend 16 days ago
62%
Bearish Trend 11 days ago
81%
BollingerBands
ODDS (%)
N/A
Bearish Trend 10 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 10 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with ITOS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then ITOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-0.03%
ITOS - BMRN
50%
Loosely correlated
+17.94%
IBO - BMRN
46%
Loosely correlated
-6.44%
IONS - BMRN
43%
Loosely correlated
-2.67%
TECH - BMRN
40%
Loosely correlated
-1.56%
KRYS - BMRN
40%
Loosely correlated
-2.44%
More

ITOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with BMRN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
+17.94%
BMRN - ITOS
49%
Loosely correlated
-0.03%
IMNM - ITOS
47%
Loosely correlated
+0.35%
IBO - ITOS
46%
Loosely correlated
-6.44%
RCUS - ITOS
45%
Loosely correlated
+1.11%
BDTX - ITOS
44%
Loosely correlated
-2.93%
More